Key facts
- Notable investors include Acumen Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MedMatrix
- ·The full record, as it builds
Funding rounds
No funding rounds for MedMatrix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedMatrix
Operator of the healthcare management system intended to streamline the delivery of specialty medications. The company's platform offers real-time information, personalized medication delivery, and cost-saving measures by minimizing waste and inefficiencies, enabling patients to access timely and affordable care while ensuring accurate and personalized treatment based on individual needs and preferences.
- Sector
- Healthcare
- HQ
- Raleigh, NC, United States
- Founded
- 2022
- Website
- medmatrix-rx.com/
- Ownership
- Privately Held (backing)
MedMatrix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedMatrix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedMatrix in its N-PORT filings yet. We sweep new filings monthly.